LEADER 03425nam 22006015 450 001 9910300081403321 005 20250709120242.0 010 $a1-4939-0443-4 024 7 $a10.1007/978-1-4939-0443-3 035 $a(CKB)3710000000094961 035 $a(EBL)1697852 035 $a(OCoLC)881165996 035 $a(SSID)ssj0001187002 035 $a(PQKBManifestationID)11644347 035 $a(PQKBTitleCode)TC0001187002 035 $a(PQKBWorkID)11242760 035 $a(PQKB)10915641 035 $a(MiAaPQ)EBC1697852 035 $a(DE-He213)978-1-4939-0443-3 035 $a(PPN)177823704 035 $a(EXLCZ)993710000000094961 100 $a20140326d2014 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aAtlas of Endocrine Pathology /$fby Lori A. Erickson 205 $a1st ed. 2014. 210 1$aNew York, NY :$cSpringer New York :$cImprint: Springer,$d2014. 215 $a1 online resource (208 p.) 225 1 $aAtlas of Anatomic Pathology,$x2625-3380 300 $aDescription based upon print version of record. 311 08$a1-4939-0442-6 320 $aIncludes bibliographical references and index. 327 $aThyroid Histology -- Thyroiditis -- Graves Disease (Diffuse Hyperplasia) -- Thyroid Goiter -- Papillary Thyroid Carcinoma -- Hyalinizing Trabecular Tumor -- Follicular Thyroid Neoplasms -- Hurthle Cell Thyroid Neoplasms -- Poorly Differentiated Thyroid Carcinoma -- Anaplastic Thyroid Carcinoma -- Tumors of C Cells -- Unusual Thyroid Tumors -- Metastases to Thyroid -- Parathyroid Histology -- Parathyroid Hyperplasia -- Parathyroid Adenoma -- Parathyroid Carcinoma -- Parathyromatosis -- Metastases to Parathyroid -- Adrenal Gland Histology -- Adrenal Cysts -- Adrenal Cortical Hyperplasia -- Adrenal Cortical Adenoma -- Adrenal Cortical Carcinoma -- Adrenal Myelolipoma -- Pheochromocytoma and Adrenal Medullary Hyperplasia -- Ganglioneuroma and Neuroblastoma -- Unusual Adrenal Tumors -- Metastases to the Adrenal Gland. 330 $aAtlas of Endocrine Pathology provides a comprehensive compendium of photomicrographs of common and uncommon entities in endocrine pathology. The volume includes histologic features of normal features, reactive conditions, hyperplasia, and tumors. The most helpful diagnostic features are illustrated to provide direction and clues to the diagnosis of endocrine tumors. Furthermore, photomicrographs highlight the most pertinent diagnostic features in problematic diagnoses in endocrine pathology.  Authored by a nationally and internationally recognized pathologist, Atlas of Endocrine Pathology is an important learning tool for those becoming familiar with the diverse entities encountered in endocrine pathology and a valuable reference for practicing pathologists faced with challenging diagnoses in endocrine pathology. 410 0$aAtlas of Anatomic Pathology,$x2625-3380 606 $aPathology 606 $aEndocrinology 606 $aPathology 606 $aEndocrinology 615 0$aPathology. 615 0$aEndocrinology. 615 14$aPathology. 615 24$aEndocrinology. 676 $a612.4 676 $a616.4 700 $aErickson$b Lori A$4aut$4http://id.loc.gov/vocabulary/relators/aut$0755321 906 $aBOOK 912 $a9910300081403321 996 $aAtlas of Endocrine Pathology$91521896 997 $aUNINA LEADER 04570nam 2201285z- 450 001 9910557437003321 005 20210501 035 $a(CKB)5400000000043353 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/69362 035 $a(oapen)doab69362 035 $a(EXLCZ)995400000000043353 100 $a20202105d2020 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aRadiopharmaceuticals for PET Imaging - Issue A 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2020 215 $a1 online resource (212 p.) 311 08$a3-03943-242-7 311 08$a3-03943-243-5 330 $aPositron emission tomography (PET) is a very useful technique for medical diagnosis and drug development. Radiopharmaceuticals are a key element in PET techniques and one of the pivotal factors influencing the applications of PET. The aim of this Special Issue of Molecules is to report on the recent research work on a number of aspects of PET radiopharmaceuticals and their preclinical and clinical use. More specifically, the content of this Special Issue includes but is not limited to radiolabeling design, radiosynthesis, synthesis techniques, quality control methodologies, GMP production methods, product formulation, in vitro and in vivo preclinical PET evaluations, clinical evaluations, dosimetry, stability study and metabolite analysis, and modeling. 606 $aMedicine$2bicssc 610 $a(S)-(?)-[18F]fluspidine 610 $a[11C]carfentanil 610 $a[18F]AlF 610 $a[18F]FACH 610 $a18F-fluorodeoxyglucose 610 $a18F-labeled analog of FACH 610 $aaffibody molecule 610 $aAlF-radiolabelling 610 $aanimal model 610 $abioconjugation 610 $abioorthogonal chemistry 610 $ablood-brain barrier (BBB) 610 $acarfentanil 610 $aclinical outcomes 610 $aEGFR 610 $aFACH 610 $afentanyl 610 $afluorine-18 610 $agallium-68 610 $aimage-based internal dosimetry 610 $aimaging-based biomarker 610 $aindium-11 610 $ainfection 610 $ainflammation 610 $ainverse electron-demand Diels-Alder ligation 610 $aisotopic exchange 610 $akinetic analysis 610 $alinker 610 $aMCT1/MCT4 lactate transporter inhibitor 610 $ametabolic stability 610 $amolecular imaging 610 $amonocarboxylate transporters (MCTs) 610 $amultiple myeloma 610 $analoxone 610 $ananobody 610 $aNODAGA 610 $aNOTA 610 $aOLINDA 610 $aopioid 610 $aorthotopic xenograft of glioblastoma in mouse 610 $aosteomyelitis 610 $aoverdose 610 $apeptides 610 $aPET 610 $aPET imaging 610 $aPET radiotracers 610 $apharmacokinetics 610 $aPODS 610 $apositron emission tomography 610 $apositron emission tomography (PET) imaging 610 $apositron emission tomography (PET), defluorination 610 $apositron emission tomography/computed tomography 610 $apreclinical development 610 $apreclinical radiopharmaceutical dosimetry 610 $aproteolysis 610 $aradiation safety 610 $aradiochemistry 610 $aradiopharmaceuticals 610 $areceptor occupancy 610 $aSiglec-9 610 $asigma-1 receptor availability 610 $asilicon-based fluoride acceptor 610 $asingle-domain antibody 610 $asmall animal Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) 610 $aSPECT 610 $aStaphylococcus aureus 610 $asub-millimetre resolution 610 $aSV2A protein 610 $asynaptic loss 610 $atetrazine 610 $atetrazine ligation 610 $athiol-reactive 610 $atumor imaging 610 $aVAP-1 610 $avascular adhesion protein 610 $avulnerable plaque 610 $a?-CCA 615 7$aMedicine 700 $aRoivainen$b Anne$4edt$01323768 702 $aLi$b Xiang-Guo$4edt 702 $aRoivainen$b Anne$4oth 702 $aLi$b Xiang-Guo$4oth 906 $aBOOK 912 $a9910557437003321 996 $aRadiopharmaceuticals for PET Imaging - Issue A$93035833 997 $aUNINA